Lilly’s (LLY) recent climb to reach a $1T market cap will come under scrutiny in the coming days when Novo Nordisk (NVO) ...

Eli Lilly and Company (India) on Tuesday said it has received approval from national drug regulator CDSCO for a drug to treat ...

Against a backdrop of exciting new developments in disease management, there is a need to improve access to innovation in ...

Studies from Novo Nordisk due early next month will give the strongest indication yet of whether blockbuster GLP-1 drugs - a ...

Eli Lilly and Company (India) has secured marketing authorization for donanemab (350 mg/20 mL administered every four weeks ...

Eli Lilly (NYSE:LLY) just landed a meaningful international win after India's drug regulator approved donanemab, the ...

Eli Lilly has secured marketing authorization from India's CDSCO for its Alzheimer's drug, donanemab. This new ...

Eli Lilly has received CDSCO approval for donanemab, an Alzheimer's treatment for adults in early symptomatic stages ...

Eli Lilly on Friday crossed the $1 trillion market-cap threshold, becoming the first drugmaker to ever reach that milestone.

Eli Lilly just hit a new kind of orbit. Investors pushed Eli Lilly past the $1 trillion mark on Friday as its shares climbed ...

Studies from Novo Nordisk due early next month will give the strongest indication yet of whether blockbuster GLP-1 drugs - a ...